Recent Advances in Clinical Oncology

Prescott, Lawrence M. Ph.D.

• This article, which contains highlights from the 41^stAnnual Meeting of the American Society of Clinical Oncology (www.asco.org), was written by Lawrence M. Prescott, Ph.D. He may be contacted via e-mail at [email protected].

Reprints of this article are available. For more information visit www.drugandmarket.com/journal and click the "Reprints" link.

Drug & Market Development 16(8):p 1049-1053, August 2005.

• There are currently over 200 oncology drugs in clinical development. Some of the latest developments in clinical oncology, including treatment of cancers such as breast, head and neck, lung, pancreatic, colorectal, and prostate as well as non-Hodgkin's lymphoma, are discussed. The studies presented include a variety of pharmacologic, biotherapeutic, and immunotherapeutic regimens that demonstrate significantly improved anti-tumor activity, markedly enhanced disease-free and overall survival, and a reduction in adverse events related to treatment.